Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2000Proceedings of the National Academy of SciencesOpen Access

The Ebola virus VP35 protein functions as a type I IFN antagonist

View Full Paper
Ask AI
Bookmark
Share

Authors

CBChristopher F. BaslerIcahn School of Medicine at Mount SinaiXWXiuyan WangMemorial Sloan Kettering Cancer CenterEMElke MühlbergerBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Basler et al. (2000) studied this question.

synapsesocial.com/papers/6a0dad2f88250cfcc2a512f8https://doi.org/10.1073/pnas.220398297
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Binding of influenza A virus NS1 protein to dsRNA in vitro1992 · 195 citations
  2. 2Interferon Action: RNA Cleavage Pattern of a (2′-5′)Oligoadenylate—Dependent Endonuclease1981 · 368 citations
  3. 3Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach2000 · 321 citations
  4. 4Comparison of the Transcription and Replication Strategies of Marburg Virus and Ebola Virus by Using Artificial Replication Systems1999 · 495 citations
  5. 5Bovine Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Cooperatively Antagonize Alpha/Beta Interferon-Induced Antiviral Response2000 · 245 citations